Page 4 - Generic Drugs

Zydus Lifesciences gets USFDA nod for generic drug to treat chest pain

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market Nitroglycerin Sublingual tablets, used to treat chest pain, in the American market.

Multiple near-term concerns trigger Divi's Laboratories' headache

Pfizer's oral Covid drug, weak sales of generics, and valuations may cap upsides

Drug firm Lupin launches generic Fenofibrate capsules in United States

Lupin on Wednesday said it has launched the capsules

Dr Reddy's, Natco Pharma launch generic cancer drug in Canada

Dr Reddy's Laboratories and Natco Pharma on Thursday said they have launched generic capsules used in the treatment of multiple myeloma and myelodysplastic syndrome patients in the Canadian market.

Lupin launches generic antifungal Tavaborole Topical Solution in US market

Drug maker Lupin on Tuesday said it has launched antifungal product Tavaborole Topical Solution in the US market.

Five pharmaceutical companies get approval to make black fungus drug

These developments come amid fast spread of the disease in various states and shortage of drugs to treat them.

Amid weak showing by biosimilars and generics, downgrade pressure on Biocon

Analysts expect ramp-up in biosimilars to be gradual

Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil

Biotechnology major Biocon on Monday said its subsidiary has joined hands with Libbs Farmaceutica to launch generic drugs in Brazil, the world's sixth most populous country.

Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

Biocon's consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year

Making markets work for affordable medicines

Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs

Pharmacy consolidation may disrupt domestic drug market: Credit Suisse

The report says if chemists are allowed to replace doctor's prescription with a generic drug, firms with high exposure to chronic therapeutic drugs will be impacted more

India seeks new preferential treatment from US on drugs, other goods

India accounts for 40 per cent of US generic drug imports, including the anti-malarial hydroxychloroquine, touted by US President Donald Trump in the fight against Covid-19.

Zydus Cadila gets USFDA nod to market generic drug to treat headache

The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, the drug firm says

US charges generic drug firm Glenmark with conspiracy in price-fixing

Company says it strongly disagreed with the charge, has 'overwhelming evidence' to support its innocence.

First copies of Gilead coronavirus drug to start selling in Bangladesh

The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals

Branded generics: Uncertainty or opportunity?

The rules of the game in India's branded generics market are fuzzy to say the least

Organised generic drugs chain Medkart Pharmacy plans national foray

By adding over 250 stores in next three years, Medkart is looking to grow its turnover from Rs 20 crore currently to Rs 300 crore in the next three years

Price-fixing charges: Sun Pharma in talks with US to end anti-trust probe

Prosecutors have been investigating allegations that generic drugmakers conspired to prop up the prices of certain widely used medications for more than five years

Pharma industry needs to develop entire value chain: Dr Reddy's G V Prasad

According to Prasad, the relevance of Indian pharma sector as a provider of affordable alternative to the world remains intact

Sun Pharma announces tie-up for China foray; to develop 8 generic products

The total addressable market size for all these eight products is about $1 billion (according to recent IQVIA data) in mainland China